INGN Inogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INGN

Price (delayed)

$5.62

Market cap

$146.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$78.35M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 21

Inogen, Inc. is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative ...

Highlights
The debt has declined by 18% year-on-year and by 5% since the previous quarter
Inogen's EPS has decreased by 45% from the previous quarter and by 31% YoY
Inogen's net income has decreased by 44% from the previous quarter and by 40% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inogen.com
Peers: ELMD RMD

Key stats

What are the main financial stats of INGN

INGN stock price

How has the Inogen stock price performed over time
Intraday
-2.26%
1 week
-16.99%
1 month
-12.46%
1 year
-20.73%
YTD
-16.37%
QTD
6.64%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$339.11M
Gross profit
$150.38M
Operating income
-$39.32M
Net income
-$35.46M
Gross margin
44.3%
Net margin
-10.5%
The net margin has declined by 46% since the previous quarter and by 38% year-on-year
Inogen's net income has decreased by 44% from the previous quarter and by 40% YoY
The operating margin has contracted by 35% from the previous quarter and by 26% YoY
INGN's operating income is down by 35% since the previous quarter and by 28% year-on-year

Price vs fundamentals

How does INGN's price correlate with its fundamentals

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.95
P/S
0.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.23
Inogen's EPS has decreased by 45% from the previous quarter and by 31% YoY
The equity has declined by 20% year-on-year and by 10% since the previous quarter
INGN's P/B is 19% below its 5-year quarterly average of 1.2 but 8% above its last 4 quarters average of 0.9
The stock's price to sales (P/S) is 50% less than its 5-year quarterly average of 0.9 and 10% less than its last 4 quarters average of 0.5

Efficiency

How efficient is Inogen business performance
Inogen's return on equity has shrunk by 52% QoQ and by 52% YoY
Inogen's ROA has plunged by 51% YoY and by 49% from the previous quarter
INGN's ROIC is down by 45% from the previous quarter and by 33% YoY
Inogen's ROS has decreased by 43% from the previous quarter and by 36% YoY

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is 145% greater than its total liabilities
The quick ratio has contracted by 18% YoY and by 3.7% from the previous quarter
INGN's total assets is down by 14% year-on-year and by 7% since the previous quarter
The debt is 90% smaller than the equity
The equity has declined by 20% year-on-year and by 10% since the previous quarter
The debt has declined by 18% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.